NCT06281756View on ClinicalTrials.gov

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

May 31, 2028

Conditions
InsomniaInsomnia ChronicInsomnia, PrimaryBlood PressureBlood Pressure, High
Interventions
BEHAVIORAL

Cognitive Behavioral Treatment for Insomnia (CBT-I)

Subjects will receive therapy for 8 weeks

DRUG

Trazodone

Non-remitting subjects will receive Trazodone (dosage) for 8 weeks

OTHER

Placebo

Non-remitting subjects will receive placebo for 8 weeks

Trial Locations (4)

17033

RECRUITING

Penn State University, Hershey

80206-2761

RECRUITING

National Jewish Health, Denver

15213-3203

RECRUITING

University of Pittsburgh, Pittsburgh

G1V 0A6

RECRUITING

Université Laval, Québec

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Milton S. Hershey Medical Center

OTHER